Literature DB >> 25989911

Therapeutic Effects of Herbal Chemicals in Traditional Chinese Medicine on Alzheimer's Disease.

T S Cheung, T H Song, T B Ng, F H Wu, L X Lao, S C W Tang, J C M Ho, K Y B Zhang, S C W Sze1.   

Abstract

Alzheimer's disease (AD) is the most common type of dementia that leads to increasing death and mental disability among humans. Current therapy of AD mainly relies on the use of acetylcholinesterase inhibitors (AChEIs) or antagonists of N-methyl-D-aspartate receptors (NMDARs), which only relieve the symptoms of the disease but not halt its progression. Nevertheless, Traditional Chinese medicines (TCM) are highly prized as many bioactive components isolated from TCM are beneficial for treating AD. In this review, we summarize the latest information on TCM and the bioactive components according to their mechanistic role in alleviating AD. They act as modulators of α- and β-secretases, and inhibitors of betaamyloid (Aβ) aggregation. Some of them suppress Aβ-induced neuronal cytotoxicity and inflammation. Hence, this work has demonstrated the feasibility of applying TCM in AD therapy and the possibility of screening of constituents in TCM in the near future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25989911     DOI: 10.2174/0929867322666150520095509

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  Quercetin enrich diet during the early-middle not middle-late stage of alzheimer's disease ameliorates cognitive dysfunction.

Authors:  Yaqin Lu; Qi Liu; Qin Yu
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.

Authors:  Zhao-Xu Zhang; Rui-Ping Zhao; De-Sheng Wang; Yan-Bing Li
Journal:  Neurochem Res       Date:  2016-08-12       Impact factor: 3.996

Review 3.  AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease.

Authors:  Yu Wang; Hao Wang; Hong-zhuan Chen
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

4.  The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer's disease.

Authors:  Kuo-Hsuan Chang; I-Cheng Chen; Hsuan-Yuan Lin; Hsuan-Chiang Chen; Chih-Hsin Lin; Te-Hsien Lin; Yu-Ting Weng; Chih-Ying Chao; Yih-Ru Wu; Jung-Yaw Lin; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  Drug Des Devel Ther       Date:  2016-02-29       Impact factor: 4.162

5.  A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial.

Authors:  Junying Zhang; Zhen Liu; Huamin Zhang; Caishui Yang; He Li; Xin Li; Kewei Chen; Zhanjun Zhang
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

Review 6.  Therapeutic Effects of Natural Drugs on Alzheimer's Disease.

Authors:  Yuan Ma; Man-Wen Yang; Xin-Wei Li; Jian-Wei Yue; Jun-Zong Chen; Mei-Wen Yang; Xuan Huang; Lian-Lian Zhu; Fen-Fang Hong; Shu-Long Yang
Journal:  Front Pharmacol       Date:  2019-12-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.